These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15841508)

  • 1. Building a strategy for maximizing intellectual property value.
    Barrett WA
    Nat Biotechnol; 2005 Mar; 23(3):387-9. PubMed ID: 15841508
    [No Abstract]   [Full Text] [Related]  

  • 2. Trendspotting: a shift in intellectual property focus.
    Anderegg MH; Thayer JM; Williams KM
    Nat Biotechnol; 2006 Jun; 24(6):609-11. PubMed ID: 16862639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The public-private structure of intellectual property ownership in agricultural biotechnology.
    Graff GD; Cullen SE; Bradford KJ; Zilberman D; Bennett AB
    Nat Biotechnol; 2003 Sep; 21(9):989-95. PubMed ID: 12949559
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrating intellectual property within the organizational social structure.
    Daizadeh I
    Nat Biotechnol; 2003 May; 21(5):573-5. PubMed ID: 12721578
    [No Abstract]   [Full Text] [Related]  

  • 5. Shareholders flex their muscles.
    Thiel K
    Nat Biotechnol; 2008 Jan; 26(1):19-21. PubMed ID: 18183007
    [No Abstract]   [Full Text] [Related]  

  • 6. Reverse mergers attract top-tier biotechs in sluggish IPO market.
    Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):598-9. PubMed ID: 16763574
    [No Abstract]   [Full Text] [Related]  

  • 7. Selling out.
    Martin JF
    Nat Biotechnol; 2010 Apr; 28(4):315-7. PubMed ID: 20383912
    [No Abstract]   [Full Text] [Related]  

  • 8. Commercializing biotechnology in the UK.
    Searle S; Graves B; Towler C
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE33-5. PubMed ID: 12874976
    [No Abstract]   [Full Text] [Related]  

  • 9. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 10. Spanish wishful thinking towards biotech.
    Sheridan C
    Nat Biotechnol; 2005 Mar; 23(3):385. PubMed ID: 15841507
    [No Abstract]   [Full Text] [Related]  

  • 11. Investing in nanotechnology.
    Paull R; Wolfe J; Hébert P; Sinkula M
    Nat Biotechnol; 2003 Oct; 21(10):1144-7. PubMed ID: 14520393
    [No Abstract]   [Full Text] [Related]  

  • 12. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 13. Partnerships in African crop biotech.
    Ayele S; Chataway J; Wield D
    Nat Biotechnol; 2006 Jun; 24(6):619-21. PubMed ID: 16763585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marriage guidance for collaborators.
    Hogan J
    Med Device Technol; 2005 Mar; 16(2):25-6. PubMed ID: 15828497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riding the risk cycle.
    Chandwani R; Portman S
    Nat Biotechnol; 2004 Sep; 22(9):1187. PubMed ID: 15384190
    [No Abstract]   [Full Text] [Related]  

  • 16. Open innovation or open house: how to protect your most valuable assets.
    Hogan J
    Med Device Technol; 2005 Apr; 16(3):30-1. PubMed ID: 15871422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splurge or merge?
    Jacobs T
    Nat Biotechnol; 2003 May; 21(5):485. PubMed ID: 12721563
    [No Abstract]   [Full Text] [Related]  

  • 18. UK bidding war amidst merger mania.
    Mitchell P
    Nat Biotechnol; 2003 Apr; 21(4):343-4. PubMed ID: 12665805
    [No Abstract]   [Full Text] [Related]  

  • 19. Starting, developing and growing a medical device company.
    Kassir S
    Biomed Instrum Technol; 2009; 43(6):446-7. PubMed ID: 20041525
    [No Abstract]   [Full Text] [Related]  

  • 20. UK industry consolidation is slow despite big merger.
    Mitchell P
    Nat Biotechnol; 2003 Mar; 21(3):215. PubMed ID: 12610553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.